[A synthetic compound containing the radioisotope rhenium 186 and a chelator, hydroxyethylidene diphosphonate (HEDP). Re-HEDP functions as a bone-seeking radiopharmaceutical when it is mixed with bioactive material, hydroxyapatite (calcium phosphate ceramic) via intravenous infusion. Re-186 is a beta emitter, with a short half life, which provides local effects with limited distribution to extramedullary bone marrow tissues. Re-HEDP can be used to treat pain associated with primary and metastatic bone lesions. ( NCI )]
UMLS (NCI) C0280809 - Organophosphorus Compound
- Pharmacologic Substance